INTERNATIONAL PATENT: ASTELLAS PHARMA INC., アステラス製薬株式会社 FILES APPLICATION FOR "RECOMBINANT ADENO-ASSOCIATED VIRUS COMPRISING TRUNCATED CMV PROMOTER SEQUENCE AND/OR TRUNCATED POLYADENYLATION SEQUENCE"

GENEVA, March 17 -- ASTELLAS PHARMA INC. (5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo1038411), アステラス製薬株式会社 (東京都中央区日本橋本町二丁目５番１号) filed a patent application (PCT/JP2024/031531) for "RECOMBINANT ADENO-ASSOCIATED VIRUS COMPRISING TRUNCATED CMV PROMOTER SEQUENCE AND/OR TRUNCATED POLYADENYLATION SEQUENCE" on Sep 03, 2024. With publication no. WO/2025/053118, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which...